Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2019
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 14 Nov 2019 Status changed from active, no longer recruiting to completed.
- 30 Sep 2019 Planned End Date changed from 1 Nov 2019 to 29 Oct 2019.
- 30 Sep 2019 Planned primary completion date changed from 1 Nov 2019 to 15 Oct 2019.